diazoxide has been researched along with morphine in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.55) | 18.7374 |
1990's | 4 (18.18) | 18.2507 |
2000's | 10 (45.45) | 29.6817 |
2010's | 7 (31.82) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Creveling, CR; Daly, JW; Lewandowski, GA; McNeal, ET | 1 |
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Alarcón, S; Hernandez, J; Laorden, ML | 1 |
Baeyens, JM; Barrios, M; Robles, LI | 1 |
Lohmann, AB; Welch, SP | 2 |
Ahmadi, S; Djahanguiri, B; Jafari, MR; Zarrindast, MR | 1 |
Djahanguiri, B; Jafari, MR; Shafaghi, B; Zarrindast, MR | 1 |
Amanpour, S; Beheshtian, A; Dehpour, AR; Demehri, S; Ghazinezami, B; Kiumehr, S; Mohagheghi, MA; Nezami, BG; Rabbani, S; Rahimpour, S; Salmasi, AH | 1 |
Mohajeri, S; Zarrindast, MR | 1 |
Khalilzadeh, A; Sattari-Naeini, M; Zarrindast, MR | 1 |
Anvari, M; Khalilzadeh, A; Khalilzadeh, O; Sahebgharani, M; Zarrindast, MR | 1 |
Garg, GR; Halder, S; Khanna, N; Malhotra, RS; Mehta, AK; Sharma, KK | 2 |
Afify, EA; Khedr, MM; Nasser, SA; Omar, AG | 1 |
1 review(s) available for diazoxide and morphine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
21 other study(ies) available for diazoxide and morphine
Article | Year |
---|---|
[3H]Batrachotoxinin A 20 alpha-benzoate binding to voltage-sensitive sodium channels: a rapid and quantitative assay for local anesthetic activity in a variety of drugs.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Batrachotoxins; Calcium Channel Blockers; Cyclic AMP; Guinea Pigs; Histamine H1 Antagonists; In Vitro Techniques; Ion Channels; Neurotoxins; Sodium; Tranquilizing Agents; Tritium | 1985 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Diazoxide blocks the morphine induced lengthening of action potential duration on guinea-pig papillary muscle.
Topics: Action Potentials; Animals; Diazoxide; Electric Stimulation; Electrophysiology; Glyburide; Guinea Pigs; Heart; In Vitro Techniques; Morphine; Papillary Muscles | 1995 |
ATP-sensitive K+ channel openers inhibit morphine withdrawal.
Topics: Adenosine Triphosphate; Animals; Behavior, Animal; Benzopyrans; Body Weight; Cromakalim; Diazoxide; Dose-Response Relationship, Drug; Female; Injections, Intraventricular; Injections, Subcutaneous; Mice; Mice, Inbred Strains; Morphine; Naloxone; Potassium Channels; Pyrroles; Substance Withdrawal Syndrome | 1994 |
ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine Triphosphate; Analgesics; Animals; Cromakalim; Diazoxide; Dose-Response Relationship, Drug; Drug Interactions; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Glyburide; Injections, Intraventricular; Ion Channel Gating; Male; Mice; Mice, Inbred ICR; Morphine; Naltrexone; Narcotic Antagonists; Nociceptors; Opioid Peptides; Pain; Potassium Channels; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Somatostatin | 1999 |
Antisenses to opioid receptors attenuate ATP-gated K(+) channel opener-induced antinociception.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Adenosine Triphosphate; Analgesia; Analgesics; Animals; Cromakalim; Diazoxide; Enkephalin, D-Penicillamine (2,5)-; Male; Mice; Mice, Inbred ICR; Morphine; Nociceptors; Oligodeoxyribonucleotides, Antisense; Pain; Potassium Channels; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 1999 |
Influence of central administration ATP-dependent K+ channel on morphine state-dependent memory of passive avoidance.
Topics: Animals; ATP-Binding Cassette Transporters; Avoidance Learning; Diazoxide; Glyburide; Injections, Intraventricular; KATP Channels; Male; Memory; Mice; Morphine; Muscarinic Antagonists; Naloxone; Narcotic Antagonists; Narcotics; Parasympathetic Nervous System; Potassium Channel Blockers; Potassium Channels; Potassium Channels, Inwardly Rectifying; Scopolamine | 2004 |
Influence of potassium channel modulators on morphine state-dependent memory of passive avoidance.
Topics: Adenosine Triphosphate; Animals; Atropine; Avoidance Learning; Diazoxide; Glyburide; Male; Memory; Mice; Morphine; Motor Activity; Naloxone; Narcotic Antagonists; Potassium Channel Blockers; Potassium Channels | 2004 |
ATP-sensitive potassium channels mediate the anti-ischemic properties of ischemic and pharmacologic preconditioning in rat random-pattern skin flap.
Topics: Adenosine; Adenosine Triphosphate; Animals; Dermatologic Surgical Procedures; Diazoxide; Glyburide; Hypoglycemic Agents; Ischemia; Ischemic Preconditioning; Male; Morphine; Narcotics; Potassium Channels; Random Allocation; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Skin; Surgical Flaps; Tissue Survival; Vasodilator Agents | 2006 |
Influence of ATP-dependent K+ channels on nicotine-induced inhibition of withdrawal in morphine-dependent mice.
Topics: Adenosine Triphosphate; Analysis of Variance; Animals; Behavior, Animal; Diarrhea; Diazoxide; Dose-Response Relationship, Drug; Ganglionic Stimulants; Glyburide; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Morphine; Morphine Dependence; Naloxone; Narcotic Antagonists; Narcotics; Nicotine; Potassium Channels, Inwardly Rectifying; Substance Withdrawal Syndrome | 2006 |
Involvement of glucose and ATP-sensitive potassium (K+) channels on morphine-induced conditioned place preference.
Topics: Animals; Behavior, Animal; Conditioning, Operant; Diazoxide; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Glucose; Glyburide; Injections, Intraperitoneal; Injections, Subcutaneous; KATP Channels; Locomotion; Male; Mice; Morphine; Potassium Channel Blockers; Reward; Spatial Behavior | 2007 |
Involvement of amlodipine, diazoxide, and glibenclamide in development of morphine tolerance in mice.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Diazoxide; Drug Tolerance; Glyburide; Hypoglycemic Agents; Injections, Intraperitoneal; Male; Mice; Morphine; Narcotics; Nociceptors; Potassium Channels; Vasodilator Agents | 2008 |
Interaction of morphine and potassium channel openers on experimental models of pain in mice.
Topics: Animals; Calcium Channel Agonists; Cromakalim; Diazoxide; Drug Interactions; Drug Therapy, Combination; Female; Glyburide; Injections, Intraperitoneal; Male; Mice; Mice, Inbred Strains; Minoxidil; Morphine; Naloxone; Pain; Pain Measurement; Potassium Channels | 2011 |
Potassium channel openers exhibit cross-tolerance with morphine in two experimental models of pain.
Topics: Analgesics, Opioid; Animals; Cromakalim; Diazoxide; Drug Tolerance; Ion Channel Gating; Mice; Minoxidil; Models, Animal; Morphine; Pain; Potassium Channels | 2010 |
The involvement of K(ATP) channels in morphine-induced antinociception and hepatic oxidative stress in acute and inflammatory pain in rats.
Topics: Acute Pain; Analgesics, Opioid; Animals; Chemical and Drug Induced Liver Injury; Diazoxide; Disease Models, Animal; Glyburide; Inflammation; KATP Channels; Liver; Male; Malondialdehyde; Morphine; Oxidative Stress; Pain; Pain Measurement; Potassium Channel Blockers; Rats; Rats, Sprague-Dawley | 2013 |